Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
| Title: | Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial |
|---|---|
| Authors: | Blay, Jean-Yves, Pápai, Zsuzsanna, Tolcher, Anthony W, Italiano, Antoine, Cupissol, Didier, López-Pousa, Antonio, Chawla, Sant P, Bompas, Emmanuelle, Babovic, Nada, Penel, Nicolas, Isambert, Nicolas, Staddon, Arthur P, Saâda-Bouzid, Esma, Santoro, Armando, Franke, Fabio A, Cohen, Patrick, Le-Guennec, Solenn, Demetri, George D |
| Source: | In The Lancet Oncology May 2015 16(5):531-540 |
| Database: | ScienceDirect |
Be the first to leave a comment!